Support By : Li-lab
PATHWAY_NAME | REACTOME_ID | KEGG_ID | DRUG_NAME | PUBCHEM_CID | Datasource |
---|---|---|---|---|---|
Alzheimer's disease | R-HSA-1643685 | 0 | fenoprofen | 3342 | drug-path |
Olfactory transduction | R-HSA-9751605 | map04740 | fenoprofen | 3342 | drug-path |
Phosphatidylinositol signaling system | R-HSA-1280215 | map04070 | fenoprofen | 3342 | drug-path |
Neuroactive ligand-receptor interaction | R-HSA-5632681 | map04080 | fenoprofen | 3342 | drug-path |
Pancreatic cancer | R-HSA-9700206 | map05212 | flunixin | 38081 | drug-path |
Prostate cancer | R-HSA-2990872 | map05215 | flunixin | 38081 | drug-path |
Melanoma | Q9UHD0-PRO_0000015379 | map05218 | flunixin | 38081 | drug-path |
Regulation of actin cytoskeleton | R-HSA-392751 | map04810 | flunixin | 38081 | drug-path |
Gap junction | R-HSA-190861 | map04540 | flunixin | 38081 | drug-path |
Colorectal cancer | R-HSA-4791275 | map05210 | flunixin | 38081 | drug-path |
Basal cell carcinoma | R-HSA-5626181 | map05217 | flunixin | 38081 | drug-path |
Systemic lupus erythematosus | R-HSA-977105 | map05322 | flumetasone | 5289501 | drug-path |
Axon guidance | R-HSA-422475 | map04360 | flumetasone | 5289501 | drug-path |
Ubiquitin mediated proteolysis | R-HSA-983153 | map04120 | sulfamethoxypyridazine | 5330 | drug-path |
Alzheimer's disease | R-HSA-1643685 | 0 | sulfamethoxypyridazine | 5330 | drug-path |
Pathways in cancer | R-HSA-9824443 | map05200 | sulfamethoxypyridazine | 5330 | drug-path |
Huntington's disease | R-HSA-1643685 | 0 | sulfamethoxypyridazine | 5330 | drug-path |
Olfactory transduction | R-HSA-9751605 | map04740 | sulfamethoxypyridazine | 5330 | drug-path |
Systemic lupus erythematosus | R-HSA-977105 | map05322 | sulfamethoxypyridazine | 5330 | drug-path |
ECM-receptor interaction | R-HSA-373711 | map04512 | sulfamethoxypyridazine | 5330 | drug-path |